Science Letter
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Science Letter
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Animal Tuberculosis
Chembio edges closer to entering the $50 million veterinary TB market
April 21st, 2006
Chembio Diagnostics, Inc. (CEMI) has made substantial progress towards the launch of its PrimaTB STAT-PAK rapid test and pending completion of the external reproducibility studies and USDA facility inspection and licensure, plans commercial release of the test in late 2006. The test is for simple and rapid detection of tuberculosis (TB) in non-human primates (NHP). TB in both captive and wild animals is a significant problem in the U.S., Europe and Japan, and more effective diagnostic tools are needed. Economic costs range from loss of whole NHP colonies used in research to loss of TB-free status among cattle herds, potentially halting dairy and meat processing...
Source: Science Letter (2006-04-21)
|
